Electroacupuncture for taxane-induced peripheral neuropathy in patients with Breast Cancer during treatment

Not Applicable

Recruiting

• Conditions: chemotherapy-induced peripheral neuropathy; Cancer - Breast; Neurological - Other neurological disorders

• Registration Number: ACTRN12622000081718
• Lead Sponsor: Chris O'Brien Lifehouse Surfebruary Cancer Research Fund

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-01-21
• Last Update Posted: 6 November 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1.Age - greater than or equal to 18 years old
2.Stage I-III breast cancer.
3.Scheduled to receive weekly adjuvant or neoadjuvant paclitaxel treatments.

Exclusion Criteria

1.Prior use of acupuncture for CIPN on more than one occasion within 6 months prior to commencement of the study.
2.Peripheral neuropathy due to a pre-existing condition prior to chemotherapy (e.g., including alcoholism, diabetic, congenital neuropathy, toxic neuropathy, nerve compression or injury, neuroma).
3.Presentation of autonomic related CIPN symptoms

Study & Design

• Study Type: Interventional
• Study Design: Not specified